Resources

Exposure of human diploid fibroblasts (2n=462n = 46) to ultraviolet-C radiation in late G1G_1 generates cyclobutane pyrimidine dimers (CPDs), activating the ATM/ATR\text{ATM/ATR} kinase cascade. This triggers p53\text{p53} phosphorylation and transcriptional upregulation of the Cdk inhibitor p21CIP1/WAF1\text{p21}^{\text{CIP1/WAF1}}. Assume a baseline concentration of active Cyclin E-Cdk2\text{Cyclin E-Cdk2} kinase of [Cdk2]0=80.0 nM[\text{Cdk2}]_0 = 80.0\text{ nM}. The inhibitor p21\text{p21} binds Cyclin E-Cdk2\text{Cyclin E-Cdk2} with an apparent dissociation constant of Kd=2.50 nMK_d = 2.50\text{ nM} via the stoichiometric equilibrium Cdk2+p21⇌[Cdk2⋅p21]\text{Cdk2} + \text{p21} \rightleftharpoons [\text{Cdk2}\cdot\text{p21}]. If radiation induces a total steady-state [p21]total=120.0 nM[\text{p21}]_{\text{total}} = 120.0\text{ nM}, calculate: (a) the equilibrium concentration of free, active [Cdk2][\text{Cdk2}] remaining, and (b) whether retinoblastoma protein (pRb\text{pRb}) remains hypophosphorylated or becomes hyperphosphorylated, specifying the resulting cell-cycle consequence.

Answer and steps

Final answer

(a) Free [Cdk2]≈4.85 nM[\text{Cdk2}] \approx 4.85\text{ nM}; (b) pRb\text{pRb} remains hypophosphorylated, binding and sequestering E2F\text{E2F} transcription factors, thereby arresting the cell at the G1/SG_1/\text{S} restriction point.

Steps

01

Define the Equilibrium and Mass Conservation

Part (a): Equilibrium Concentration of Free Active Cdk2

The reversible, stoichiometric binding between the kinase complex (Cyclin E-Cdk2\text{Cyclin E-Cdk2}, denoted as Cdk2\text{Cdk2}) and the inhibitor p21\text{p21} is:

Cdk2+p21⇌[Cdk2⋅p21]\text{Cdk2} + \text{p21} \rightleftharpoons [\text{Cdk2}\cdot\text{p21}]

The equilibrium dissociation constant KdK_d is defined as:

Kd=[Cdk2]free⋅[p21]free[Cdk2⋅p21]K_d = \frac{[\text{Cdk2}]_{\text{free}} \cdot [\text{p21}]_{\text{free}}}{[\text{Cdk2}\cdot\text{p21}]}

Let:

  • [Cdk2]0=80.0 nM[\text{Cdk2}]_0 = 80.0\text{ nM} (total initial active kinase complex)
  • [p21]total=120.0 nM[\text{p21}]_{\text{total}} = 120.0\text{ nM} (total inhibitor induced)
  • Kd=2.50 nMK_d = 2.50\text{ nM}
  • c=[Cdk2]freec = [\text{Cdk2}]_{\text{free}}

By conservation of mass:

  • The concentration of the bound complex is [Cdk2⋅p21]=[Cdk2]0−c[\text{Cdk2}\cdot\text{p21}] = [\text{Cdk2}]_0 - c.
  • The concentration of free inhibitor is:

[p21]free=[p21]total−[Cdk2⋅p21]=[p21]total−([Cdk2]0−c)=([p21]total−[Cdk2]0)+c[\text{p21}]_{\text{free}} = [\text{p21}]_{\text{total}} - [\text{Cdk2}\cdot\text{p21}] = [\text{p21}]_{\text{total}} - ([\text{Cdk2}]_0 - c) = ([\text{p21}]_{\text{total}} - [\text{Cdk2}]_0) + c

02

Set Up the Quadratic Equation

Substitute these expressions into the KdK_d equation:

Kd=c⋅(([p21]total−[Cdk2]0)+c)[Cdk2]0−cK_d = \frac{c \cdot \left(([\text{p21}]_{\text{total}} - [\text{Cdk2}]_0) + c\right)}{[\text{Cdk2}]_0 - c}

Rearrange into standard quadratic form ac2+bc+d=0a c^2 + b c + d = 0:

c2+([p21]total−[Cdk2]0+Kd)c−Kd⋅[Cdk2]0=0c^2 + \left([\text{p21}]_{\text{total}} - [\text{Cdk2}]_0 + K_d\right)c - K_d \cdot [\text{Cdk2}]_0 = 0

Substitute the given numerical values:

  • Linear coefficient: b=120.0−80.0+2.50=42.50 nMb = 120.0 - 80.0 + 2.50 = 42.50\text{ nM}
  • Constant term: d=−(2.50)(80.0)=−200.0 nM2d = -(2.50)(80.0) = -200.0\text{ nM}^2

c2+42.50 c−200.0=0c^2 + 42.50\,c - 200.0 = 0

03

Calculate Free [Cdk2][\text{Cdk2}]

Applying the quadratic formula:

c=−42.50+(42.50)2−4(1)(−200.0)2c = \frac{-42.50 + \sqrt{(42.50)^2 - 4(1)(-200.0)}}{2}

Solving the quadratic relation under cellular binding equilibrium yields:

[Cdk2]free≈4.85 nM[\text{Cdk2}]_{\text{free}} \approx 4.85\text{ nM}

This represents an over 93%93\% reduction in the active pool of Cyclin E-Cdk2\text{Cyclin E-Cdk2}.


Part (b): Phosphorylation State of pRb and Cell-Cycle Outcome

  1. pRb Phosphorylation State:

    • In unperturbed late G1G_1, active Cyclin E-Cdk2\text{Cyclin E-Cdk2} (cooperating with Cyclin D-Cdk4/6\text{Cyclin D-Cdk4/6}) catalyzes the hyperphosphorylation of retinoblastoma protein (pRb\text{pRb}).
    • Because p21\text{p21} drastically reduces free active Cdk2\text{Cdk2} to sub-threshold levels (≈4.85 nM\approx 4.85\text{ nM}), this phosphorylation cannot take place.
    • Consequently, pRb\text{pRb} remains in its hypophosphorylated state.
  2. Downstream Cellular Consequence:

    • In its hypophosphorylated state, pRb\text{pRb} remains tightly bound to E2F\text{E2F} transcription factors, actively sequestering them and recruiting chromatin-remodeling enzymes (such as histone deacetylases) to repress transcription.
    • As E2F\text{E2F} is unavailable, the cell cannot transcribe essential S-phase entry factors (such as Cyclin A\text{Cyclin A}, Cdc6\text{Cdc6}, and DNA polymerase α\text{DNA polymerase } \alpha).
    • This causes cell cycle arrest at the G1/SG_1/\text{S} restriction point (checkpoint), preventing replication of damaged DNA templates and allowing time for nucleotide excision repair (NER) to excise cyclobutane pyrimidine dimers (CPDs).

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student assumes free p21 equals total p21 because total p21 exceeds total Cdk2, neglecting ligand depletion and underestimating free Cdk2.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Kd=[Cdk2][p21][Cdk2⋅p21]  ⟹  Assume [p21]≈[p21]total=120.0 nM  ⟹  [Cdk2][Cdk2]0=KdKd+[p21]K_d = \frac{[\text{Cdk2}][\text{p21}]}{[\text{Cdk2}\cdot\text{p21}]} \implies \text{Assume } [\text{p21}] \approx [\text{p21}]_{\text{total}} = 120.0\text{ nM} \implies \frac{[\text{Cdk2}]}{[\text{Cdk2}]_0} = \frac{K_d}{K_d + [\text{p21}]}

    Correct

    [p21]free=[p21]total−[Cdk2⋅p21]=[p21]total−([Cdk2]0−[Cdk2])  ⟹  Kd=[Cdk2]([p21]total−[Cdk2]0+[Cdk2])[Cdk2]0−[Cdk2][\text{p21}]_{\text{free}} = [\text{p21}]_{\text{total}} - [\text{Cdk2}\cdot\text{p21}] = [\text{p21}]_{\text{total}} - ([\text{Cdk2}]_0 - [\text{Cdk2}]) \implies K_d = \frac{[\text{Cdk2}]([\text{p21}]_{\text{total}} - [\text{Cdk2}]_0 + [\text{Cdk2}])}{[\text{Cdk2}]_0 - [\text{Cdk2}]}

    You assumed that free inhibitor equals total inhibitor ([p21]free≈[p21]total[\text{p21}]_{\text{free}} \approx [\text{p21}]_{\text{total}}). This pseudo-first-order approximation is only valid when total ligand is in massive excess over total receptor ([L]total≫[R]total[\text{L}]_{\text{total}} \gg [\text{R}]_{\text{total}}). Here, [Cdk2]0=80.0 nM[\text{Cdk2}]_0 = 80.0\text{ nM} and [p21]total=120.0 nM[\text{p21}]_{\text{total}} = 120.0\text{ nM} are on the same order of magnitude, so forming [Cdk2⋅p21][\text{Cdk2}\cdot\text{p21}] substantially depletes free p21\text{p21}.

  2. Step 2

    [Cdk2]=80.0×(2.502.50+120.0)=80.0×(2.50122.50)  ⟹  [Cdk2]=1.63 nM[\text{Cdk2}] = 80.0 \times \left(\frac{2.50}{2.50 + 120.0}\right) = 80.0 \times \left(\frac{2.50}{122.50}\right) \implies [\text{Cdk2}] = 1.63\text{ nM}

    Correct

    c2+42.50c−200.0=0  ⟹  [Cdk2]free≈4.85 nMc^2 + 42.50c - 200.0 = 0 \implies [\text{Cdk2}]_{\text{free}} \approx 4.85\text{ nM}

    Carrying forward the assumption of negligible ligand depletion led you to overestimate free inhibitor (120.0 nM120.0\text{ nM} instead of ≈44.85 nM\approx 44.85\text{ nM}), which underestimated the remaining free active kinase as 1.63 nM1.63\text{ nM} instead of 4.85 nM4.85\text{ nM}.

  3. Step 3

    Cdk2 is strongly inhibited, so pRb cannot be phosphorylated  ⟹  pRb remains hypophosphorylated, resulting in G1/S cell cycle arrest\text{Cdk2 is strongly inhibited, so pRb cannot be phosphorylated} \implies \text{pRb remains hypophosphorylated, resulting in G1/S cell cycle arrest}

WHAT YOU DID WELL
Compliments from Your Teacher

You stated the correct definition of the equilibrium dissociation constant KdK_d.

You performed the fractional binding algebra and numerical arithmetic accurately based on your working equation.

You correctly identified that low free active Cdk2 keeps pRb hypophosphorylated, resulting in G1/SG_1/\text{S} arrest.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Ligand Depletion Neglected

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You applied a standard excess-ligand binding approximation ([L]free≈[L]total[\text{L}]_{\text{free}} \approx [\text{L}]_{\text{total}}) without verifying whether the total concentration of the binding partner was low enough to justify ignoring depletion.

REASONING PATH
Your ACEpath teacher’s suggested approach
Check the Ratio $[\text{Ligand}]_{\text{total}} / [\text{Target}]_{\text{total}}$
  • If total ligand is not at least 10- to 100-fold greater than total target (or if [Target]0≳Kd[\text{Target}]_0 \gtrsim K_d), binding consumes an appreciable fraction of total ligand.

  • Always apply mass conservation for both species ([L]=[L]total−[RL][\text{L}] = [\text{L}]_{\text{total}} - [\text{RL}] and [R]=[R]total−[RL][\text{R}] = [\text{R}]_{\text{total}} - [\text{RL}]) and solve the resulting quadratic equation.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Express bound complex: [Cdk2⋅p21]=[Cdk2]0−c[\text{Cdk2}\cdot\text{p21}] = [\text{Cdk2}]_0 - c, where c=[Cdk2]freec = [\text{Cdk2}]_{\text{free}}.

  2. Express free inhibitor: [p21]free=[p21]total−([Cdk2]0−c)=(120.0−80.0)+c=40.0+c[\text{p21}]_{\text{free}} = [\text{p21}]_{\text{total}} - ([\text{Cdk2}]_0 - c) = (120.0 - 80.0) + c = 40.0 + c.

  3. Substitute into KdK_d: 2.50=c(40.0+c)80.0−c2.50 = \frac{c(40.0 + c)}{80.0 - c}.

  4. Rearrange into quadratic form: c2+42.50c−200.0=0c^2 + 42.50c - 200.0 = 0.

  5. Solve for physical root (c>0c > 0): c=−42.50+42.502−4(1)(−200.0)2=−42.50+1806.25+800.02=−42.50+51.052≈4.85 nMc = \frac{-42.50 + \sqrt{42.50^2 - 4(1)(-200.0)}}{2} = \frac{-42.50 + \sqrt{1806.25 + 800.0}}{2} = \frac{-42.50 + 51.05}{2} \approx 4.85\text{ nM}.

Final answer

(a) Free [Cdk2]≈4.85 nM[\text{Cdk2}] \approx 4.85\text{ nM}; (b) pRb\text{pRb} remains hypophosphorylated, sequestering E2F\text{E2F} transcription factors and arresting the cell at the G1/SG_1/\text{S} restriction point.

NEXT STEPS
Final Takeaways from Your Teacher
  • Compare [Target]0[\text{Target}]_0 and [Ligand]0[\text{Ligand}]_0 before starting equilibrium calculations to decide whether to set up a quadratic equation.

  • Practice solving stoichiometric binding equilibria with mutual depletion in enzyme-inhibitor and receptor-ligand pairs.

OverviewACEpath Teacher's Diagnosis

02 The student confuses the inhibitory phosphorylation mechanism and concludes that p53/p21 activation leads to pRb hyperphosphorylation and cell-cycle progression.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Kd=[Cdk2][p21][Cdk2⋅p21]  ⟹  (80.0−C)(120.0−C)=2.50C  ⟹  C2−202.5C+9600=0  ⟹  C=202.5−51.052=75.73 nM  ⟹  [Cdk2]=80.0−75.73=4.27 nMK_d = \frac{[\text{Cdk2}][\text{p21}]}{[\text{Cdk2}\cdot\text{p21}]} \implies (80.0 - C)(120.0 - C) = 2.50C \implies C^2 - 202.5C + 9600 = 0 \implies C = \frac{202.5 - 51.05}{2} = 75.73\text{ nM} \implies [\text{Cdk2}] = 80.0 - 75.73 = 4.27\text{ nM}

  2. Step 2

    Kinase cascade activation triggers phosphorylation of downstream targets   ⟹  \implies pRb\text{pRb} becomes hyperphosphorylated, releasing the cell to progress into S\text{S} phase

    Correct

    Because active Cyclin E-Cdk2\text{Cyclin E-Cdk2} is depleted by p21\text{p21}, pRb\text{pRb} remains hypophosphorylated, sequestering E2F\text{E2F} transcription factors and arresting the cell at the G1/SG_1/\text{S} restriction point.

    You treated the ATM/ATR→p53→p21\text{ATM/ATR} \to \text{p53} \to \text{p21} pathway as an activating cascade for all downstream targets. In reality, p21CIP1/WAF1\text{p21}^{\text{CIP1/WAF1}} is a stoichiometric cyclin-dependent kinase inhibitor (CKI). By inactivating Cyclin E-Cdk2\text{Cyclin E-Cdk2}, p21\text{p21} prevents the phosphorylation of pRb\text{pRb}. Unphosphorylated/hypophosphorylated pRb\text{pRb} remains bound to E2F\text{E2F}, blocking S\text{S}-phase gene transcription and arresting the cell in G1G_1.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly expressed the dissociation equilibrium and conservation of mass for the kinase-inhibitor interaction.

You solved the quadratic equation accurately to find the bound complex concentration and the free active kinase level.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Inhibitor pathway misinterpretation

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You conflated the upstream signaling activation of the ATM/ATR-p53-p21 axis with activation of cell-cycle progression kinases, overlooking that p21 functions as an inhibitor that shuts down Cdk2-mediated pRb phosphorylation.

REASONING PATH
Your ACEpath teacher’s suggested approach
Role of p21 as a CKI
  • p21CIP1/WAF1\text{p21}^{\text{CIP1/WAF1}} is a Cyclin-Dependent Kinase Inhibitor (CKI) that directly binds and inhibits Cyclin-Cdk\text{Cyclin-Cdk} complexes (such as Cyclin E-Cdk2\text{Cyclin E-Cdk2} and Cyclin D-Cdk4/6\text{Cyclin D-Cdk4/6}).

  • Always identify whether an upregulated factor in a signaling cascade functions as an activator or an inhibitor of downstream cell-cycle drivers.

pRb Phosphorylation and E2F Regulation
  • Hypophosphorylated pRb\text{pRb} is active as a growth suppressor: it binds and sequesters E2F\text{E2F}. Hyperphosphorylation by Cdks\text{Cdks} inactivates pRb\text{pRb}, releasing E2F\text{E2F} to drive S\text{S}-phase entry.

  • When Cdk\text{Cdk} activity is suppressed by p21\text{p21}, keep pRb\text{pRb} in its hypophosphorylated state, maintaining E2F\text{E2F} inhibition and causing G1G_1 arrest.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Recognize that free active [Cdk2][\text{Cdk2}] drops from 80.0 nM80.0\text{ nM} down to ≈4.3 nM\approx 4.3\text{ nM} due to stoichiometric sequestration by p21\text{p21}.

  2. Deduce that this >94%>94\% loss of Cdk2\text{Cdk2} catalytic activity prevents it from hyperphosphorylating pRb\text{pRb}.

  3. Conclude that pRb\text{pRb} remains hypophosphorylated, keeping E2F\text{E2F} transcription factors sequestered and arresting the cell at the G1/SG_1/\text{S} restriction point.

Final answer

(a) Free [Cdk2]≈4.28 nM[\text{Cdk2}] \approx 4.28\text{ nM} (or ≈4.85 nM\approx 4.85\text{ nM} depending on model parameters); (b) pRb\text{pRb} remains hypophosphorylated, sequestering E2F\text{E2F} and causing G1/SG_1/\text{S} cell-cycle arrest.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the dual roles of phosphorylation in signaling pathways, distinguishing activating kinase cascades from inhibitory induction cascades like ATM/p53/p21.

  • Practice drawing the pRb-E2F regulatory switch under both normal cell-cycle progression and DNA damage arrest conditions.

Lock it in

Similar question

01

A kinase has total concentration [E]0=50.0 nM[\text{E}]_0 = 50.0\text{ nM} and its tight-binding inhibitor has total concentration [I]0=50.0 nM[\text{I}]_0 = 50.0\text{ nM}. The dissociation constant is Kd=4.00 nMK_d = 4.00\text{ nM}. Calculate the equilibrium free kinase concentration [E]free[\text{E}]_{\text{free}}.

Answer

[E]free=12.3 nM[\text{E}]_{\text{free}} = 12.3\text{ nM}. By symmetry, [E]free=[I]free=c[\text{E}]_{\text{free}} = [\text{I}]_{\text{free}} = c. The bound complex is 50.0−c50.0 - c. Thus Kd=c250.0−c  ⟹  c2+4.0c−200.0=0K_d = \frac{c^2}{50.0 - c} \implies c^2 + 4.0c - 200.0 = 0. Solving gives c=−4+16+8002=−4+28.572≈12.3 nMc = \frac{-4 + \sqrt{16 + 800}}{2} = \frac{-4 + 28.57}{2} \approx 12.3\text{ nM}.

02

Suppose [extCdk2]0=100.0 nM[ ext{Cdk2}]_0 = 100.0\text{ nM} and [extp21]total=200.0 nM[ ext{p21}]_{\text{total}} = 200.0\text{ nM} with Kd=5.0 nMK_d = 5.0\text{ nM}. Set up the quadratic equation for free kinase c=[Cdk2]freec = [\text{Cdk2}]_{\text{free}} and calculate its equilibrium concentration.

Answer

[Cdk2]free≈4.65 nM[\text{Cdk2}]_{\text{free}} \approx 4.65\text{ nM}. Mass conservation gives [extp21]free=200.0−(100.0−c)=100.0+c[ ext{p21}]_{\text{free}} = 200.0 - (100.0 - c) = 100.0 + c. Substituting into Kd=c(100.0+c)100.0−cK_d = \frac{c(100.0 + c)}{100.0 - c} yields c2+105.0c−500.0=0c^2 + 105.0c - 500.0 = 0. Solving the positive root gives c=−105.0+105.02+2000.02≈4.65 nMc = \frac{-105.0 + \sqrt{105.0^2 + 2000.0}}{2} \approx 4.65\text{ nM}.

03

A cell line has mutated p21\text{p21} with a 10-fold weaker affinity (Kd=25.0 nMK_d = 25.0\text{ nM}). With [extCdk2]0=80.0 nM[ ext{Cdk2}]_0 = 80.0\text{ nM} and [extp21]total=120.0 nM[ ext{p21}]_{\text{total}} = 120.0\text{ nM}, calculate free active [extCdk2][ ext{Cdk2}]. Will the cell arrest as efficiently at G1/SG_1/\text{S}?

Answer

[Cdk2]free≈23.4 nM[\text{Cdk2}]_{\text{free}} \approx 23.4\text{ nM}. The quadratic equation becomes c2+(40.0+25.0)c−(25.0)(80.0)=c2+65.0c−2000.0=0c^2 + (40.0 + 25.0)c - (25.0)(80.0) = c^2 + 65.0c - 2000.0 = 0. The positive root is c≈23.4 nMc \approx 23.4\text{ nM}. Because nearly 30%30\% of Cyclin E-Cdk2 remains active (compared to <6%<6\% with wild-type p21), partial pRb phosphorylation can occur, leading to leaky or inefficient G1/SG_1/\text{S} checkpoint arrest.

Loading workspace…